KR102037543B1 - 회전 방사 재료로 커버링된 의료 기구 및 제조 방법 - Google Patents
회전 방사 재료로 커버링된 의료 기구 및 제조 방법 Download PDFInfo
- Publication number
- KR102037543B1 KR102037543B1 KR1020147019313A KR20147019313A KR102037543B1 KR 102037543 B1 KR102037543 B1 KR 102037543B1 KR 1020147019313 A KR1020147019313 A KR 1020147019313A KR 20147019313 A KR20147019313 A KR 20147019313A KR 102037543 B1 KR102037543 B1 KR 102037543B1
- Authority
- KR
- South Korea
- Prior art keywords
- delete delete
- layer
- ptfe
- medical device
- spinning
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000000034 method Methods 0.000 title claims description 83
- 239000000463 material Substances 0.000 title abstract description 221
- 238000004519 manufacturing process Methods 0.000 title description 4
- 229920001343 polytetrafluoroethylene Polymers 0.000 claims abstract description 264
- 239000004810 polytetrafluoroethylene Substances 0.000 claims abstract description 264
- 238000009987 spinning Methods 0.000 claims abstract description 208
- -1 polytetrafluoroethylene Polymers 0.000 claims abstract description 21
- 239000000835 fiber Substances 0.000 claims description 143
- 229920003171 Poly (ethylene oxide) Polymers 0.000 claims description 108
- 229920009441 perflouroethylene propylene Polymers 0.000 claims description 77
- 239000004812 Fluorinated ethylene propylene Substances 0.000 claims description 75
- 239000006185 dispersion Substances 0.000 claims description 67
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 65
- 239000000203 mixture Substances 0.000 claims description 47
- 239000011148 porous material Substances 0.000 claims description 29
- 238000005245 sintering Methods 0.000 claims description 24
- 239000012530 fluid Substances 0.000 claims description 17
- 230000028709 inflammatory response Effects 0.000 claims description 14
- 230000003463 hyperproliferative effect Effects 0.000 claims description 12
- 230000003014 reinforcing effect Effects 0.000 claims description 11
- HQQADJVZYDDRJT-UHFFFAOYSA-N ethene;prop-1-ene Chemical group C=C.CC=C HQQADJVZYDDRJT-UHFFFAOYSA-N 0.000 claims description 7
- 230000005684 electric field Effects 0.000 claims description 6
- 206010020718 hyperplasia Diseases 0.000 claims description 5
- 230000002411 adverse Effects 0.000 claims description 3
- 238000002156 mixing Methods 0.000 claims description 3
- 230000008467 tissue growth Effects 0.000 claims description 3
- 229920000642 polymer Polymers 0.000 abstract description 92
- 230000012010 growth Effects 0.000 abstract description 35
- 239000002121 nanofiber Substances 0.000 abstract description 18
- 239000010410 layer Substances 0.000 description 393
- 210000001519 tissue Anatomy 0.000 description 71
- 238000001878 scanning electron micrograph Methods 0.000 description 53
- 210000002889 endothelial cell Anatomy 0.000 description 48
- 210000004027 cell Anatomy 0.000 description 46
- 239000000243 solution Substances 0.000 description 44
- 239000002775 capsule Substances 0.000 description 43
- 238000000576 coating method Methods 0.000 description 29
- 230000035515 penetration Effects 0.000 description 29
- 239000000523 sample Substances 0.000 description 29
- 230000003511 endothelial effect Effects 0.000 description 26
- 230000008569 process Effects 0.000 description 26
- 238000002513 implantation Methods 0.000 description 21
- 239000011248 coating agent Substances 0.000 description 17
- 230000002401 inhibitory effect Effects 0.000 description 17
- 230000015572 biosynthetic process Effects 0.000 description 14
- 230000021164 cell adhesion Effects 0.000 description 14
- 230000010261 cell growth Effects 0.000 description 14
- 230000002757 inflammatory effect Effects 0.000 description 14
- 239000002609 medium Substances 0.000 description 14
- 230000001737 promoting effect Effects 0.000 description 12
- 238000002054 transplantation Methods 0.000 description 12
- 230000004044 response Effects 0.000 description 11
- 239000002904 solvent Substances 0.000 description 11
- 239000004743 Polypropylene Substances 0.000 description 10
- 230000008859 change Effects 0.000 description 10
- 238000005259 measurement Methods 0.000 description 10
- 210000004369 blood Anatomy 0.000 description 9
- 239000008280 blood Substances 0.000 description 9
- 238000003618 dip coating Methods 0.000 description 8
- 230000009969 flowable effect Effects 0.000 description 8
- 239000002245 particle Substances 0.000 description 8
- 238000003756 stirring Methods 0.000 description 8
- 102000008186 Collagen Human genes 0.000 description 7
- 108010035532 Collagen Proteins 0.000 description 7
- 238000004458 analytical method Methods 0.000 description 7
- 229920001436 collagen Polymers 0.000 description 7
- 239000012528 membrane Substances 0.000 description 7
- 229910052751 metal Inorganic materials 0.000 description 7
- 239000002184 metal Substances 0.000 description 7
- 206010061218 Inflammation Diseases 0.000 description 6
- 229920001410 Microfiber Polymers 0.000 description 6
- 208000027418 Wounds and injury Diseases 0.000 description 6
- 238000002835 absorbance Methods 0.000 description 6
- 230000008901 benefit Effects 0.000 description 6
- 230000002349 favourable effect Effects 0.000 description 6
- 230000004054 inflammatory process Effects 0.000 description 6
- 238000002844 melting Methods 0.000 description 6
- 230000008018 melting Effects 0.000 description 6
- 239000003658 microfiber Substances 0.000 description 6
- 238000012360 testing method Methods 0.000 description 6
- 239000012591 Dulbecco’s Phosphate Buffered Saline Substances 0.000 description 5
- 229910052782 aluminium Inorganic materials 0.000 description 5
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 5
- 230000006835 compression Effects 0.000 description 5
- 238000007906 compression Methods 0.000 description 5
- 238000013461 design Methods 0.000 description 5
- 239000011888 foil Substances 0.000 description 5
- 230000035876 healing Effects 0.000 description 5
- 238000010438 heat treatment Methods 0.000 description 5
- 230000003993 interaction Effects 0.000 description 5
- VMGAPWLDMVPYIA-HIDZBRGKSA-N n'-amino-n-iminomethanimidamide Chemical compound N\N=C\N=N VMGAPWLDMVPYIA-HIDZBRGKSA-N 0.000 description 5
- 230000003287 optical effect Effects 0.000 description 5
- 230000035699 permeability Effects 0.000 description 5
- 229920001223 polyethylene glycol Polymers 0.000 description 5
- 230000002787 reinforcement Effects 0.000 description 5
- 239000002356 single layer Substances 0.000 description 5
- 230000002792 vascular Effects 0.000 description 5
- 125000003821 2-(trimethylsilyl)ethoxymethyl group Chemical group [H]C([H])([H])[Si](C([H])([H])[H])(C([H])([H])[H])C([H])([H])C(OC([H])([H])[*])([H])[H] 0.000 description 4
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 4
- 239000000654 additive Substances 0.000 description 4
- 230000008512 biological response Effects 0.000 description 4
- 229910002091 carbon monoxide Inorganic materials 0.000 description 4
- 239000001913 cellulose Substances 0.000 description 4
- 229920002678 cellulose Polymers 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 4
- 239000003814 drug Substances 0.000 description 4
- 229940079593 drug Drugs 0.000 description 4
- 239000012768 molten material Substances 0.000 description 4
- 238000000879 optical micrograph Methods 0.000 description 4
- 229920002451 polyvinyl alcohol Polymers 0.000 description 4
- BOLDJAUMGUJJKM-LSDHHAIUSA-N renifolin D Natural products CC(=C)[C@@H]1Cc2c(O)c(O)ccc2[C@H]1CC(=O)c3ccc(O)cc3O BOLDJAUMGUJJKM-LSDHHAIUSA-N 0.000 description 4
- 238000004626 scanning electron microscopy Methods 0.000 description 4
- 206010019909 Hernia Diseases 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- 208000007536 Thrombosis Diseases 0.000 description 3
- 210000000709 aorta Anatomy 0.000 description 3
- 238000003556 assay Methods 0.000 description 3
- 230000004888 barrier function Effects 0.000 description 3
- 230000017531 blood circulation Effects 0.000 description 3
- 210000004204 blood vessel Anatomy 0.000 description 3
- 230000000052 comparative effect Effects 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 230000002596 correlated effect Effects 0.000 description 3
- 239000013078 crystal Substances 0.000 description 3
- 238000000151 deposition Methods 0.000 description 3
- 230000008021 deposition Effects 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 238000001523 electrospinning Methods 0.000 description 3
- 239000002657 fibrous material Substances 0.000 description 3
- 238000009501 film coating Methods 0.000 description 3
- 239000007943 implant Substances 0.000 description 3
- 238000000338 in vitro Methods 0.000 description 3
- 230000008595 infiltration Effects 0.000 description 3
- 238000001764 infiltration Methods 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 230000010354 integration Effects 0.000 description 3
- 210000004072 lung Anatomy 0.000 description 3
- 210000002540 macrophage Anatomy 0.000 description 3
- 238000001543 one-way ANOVA Methods 0.000 description 3
- 239000012188 paraffin wax Substances 0.000 description 3
- 239000005020 polyethylene terephthalate Substances 0.000 description 3
- 230000002829 reductive effect Effects 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 239000006228 supernatant Substances 0.000 description 3
- 229920001169 thermoplastic Polymers 0.000 description 3
- MEXAGTSTSPYCEP-JEDNCBNOSA-N (2s)-2,6-diaminohexanoic acid;hydrobromide Chemical compound Br.NCCCC[C@H](N)C(O)=O MEXAGTSTSPYCEP-JEDNCBNOSA-N 0.000 description 2
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 description 2
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 2
- CFBVWCHTNQHZLT-UHFFFAOYSA-N 4-methoxy-5-[3-(2-methoxy-4-nitro-5-sulfophenyl)-5-(phenylcarbamoyl)tetrazol-3-ium-2-yl]-2-nitrobenzenesulfonate Chemical compound COC1=CC([N+]([O-])=O)=C(S([O-])(=O)=O)C=C1N1[N+](C=2C(=CC(=C(C=2)S(O)(=O)=O)[N+]([O-])=O)OC)=NC(C(=O)NC=2C=CC=CC=2)=N1 CFBVWCHTNQHZLT-UHFFFAOYSA-N 0.000 description 2
- HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 description 2
- KAKZBPTYRLMSJV-UHFFFAOYSA-N Butadiene Chemical compound C=CC=C KAKZBPTYRLMSJV-UHFFFAOYSA-N 0.000 description 2
- 229920001661 Chitosan Polymers 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 description 2
- 102000009123 Fibrin Human genes 0.000 description 2
- 108010073385 Fibrin Proteins 0.000 description 2
- BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 description 2
- WZUVPPKBWHMQCE-UHFFFAOYSA-N Haematoxylin Chemical compound C12=CC(O)=C(O)C=C2CC2(O)C1C1=CC=C(O)C(O)=C1OC2 WZUVPPKBWHMQCE-UHFFFAOYSA-N 0.000 description 2
- 208000031481 Pathologic Constriction Diseases 0.000 description 2
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- PPBRXRYQALVLMV-UHFFFAOYSA-N Styrene Chemical compound C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 description 2
- 210000003484 anatomy Anatomy 0.000 description 2
- 210000002403 aortic endothelial cell Anatomy 0.000 description 2
- 238000013459 approach Methods 0.000 description 2
- 239000012620 biological material Substances 0.000 description 2
- 230000023555 blood coagulation Effects 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 230000000295 complement effect Effects 0.000 description 2
- 238000010276 construction Methods 0.000 description 2
- 230000001276 controlling effect Effects 0.000 description 2
- 238000007865 diluting Methods 0.000 description 2
- 239000002612 dispersion medium Substances 0.000 description 2
- 238000006073 displacement reaction Methods 0.000 description 2
- 229920000295 expanded polytetrafluoroethylene Polymers 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 229950003499 fibrin Drugs 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 2
- 229910052737 gold Inorganic materials 0.000 description 2
- 239000010931 gold Substances 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- 238000003780 insertion Methods 0.000 description 2
- 230000037431 insertion Effects 0.000 description 2
- 239000011229 interlayer Substances 0.000 description 2
- 230000003834 intracellular effect Effects 0.000 description 2
- 229910052742 iron Inorganic materials 0.000 description 2
- 239000003550 marker Substances 0.000 description 2
- 239000000155 melt Substances 0.000 description 2
- 239000013642 negative control Substances 0.000 description 2
- 239000011368 organic material Substances 0.000 description 2
- 229920000729 poly(L-lysine) polymer Polymers 0.000 description 2
- 229920000191 poly(N-vinyl pyrrolidone) Polymers 0.000 description 2
- 229920003223 poly(pyromellitimide-1,4-diphenyl ether) Polymers 0.000 description 2
- 229920000139 polyethylene terephthalate Polymers 0.000 description 2
- 229920001155 polypropylene Polymers 0.000 description 2
- 229920002635 polyurethane Polymers 0.000 description 2
- 239000004814 polyurethane Substances 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 238000005476 soldering Methods 0.000 description 2
- 238000005507 spraying Methods 0.000 description 2
- 238000010186 staining Methods 0.000 description 2
- 230000036262 stenosis Effects 0.000 description 2
- 208000037804 stenosis Diseases 0.000 description 2
- 238000007920 subcutaneous administration Methods 0.000 description 2
- 239000004094 surface-active agent Substances 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 210000000115 thoracic cavity Anatomy 0.000 description 2
- 230000007704 transition Effects 0.000 description 2
- 230000008733 trauma Effects 0.000 description 2
- FGKCGMMQJOWMFW-UHFFFAOYSA-M trimethyl-[2-(2-methylprop-2-enoyloxy)ethyl]azanium;bromide Chemical compound [Br-].CC(=C)C(=O)OCC[N+](C)(C)C FGKCGMMQJOWMFW-UHFFFAOYSA-M 0.000 description 2
- 229920002554 vinyl polymer Polymers 0.000 description 2
- LUEWUZLMQUOBSB-FSKGGBMCSA-N (2s,3s,4s,5s,6r)-2-[(2r,3s,4r,5r,6s)-6-[(2r,3s,4r,5s,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2r,4r,5s,6r)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@@H](O[C@@H]2[C@H](O[C@@H](OC3[C@H](O[C@@H](O)[C@@H](O)[C@H]3O)CO)[C@@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O LUEWUZLMQUOBSB-FSKGGBMCSA-N 0.000 description 1
- QKVJMFRCFAEEQY-UHFFFAOYSA-M (3-chloro-2-hydroxypropyl)-dimethyl-[2-(2-methylprop-2-enoyloxy)ethyl]azanium;chloride Chemical compound [Cl-].CC(=C)C(=O)OCC[N+](C)(C)CC(O)CCl QKVJMFRCFAEEQY-UHFFFAOYSA-M 0.000 description 1
- ZBTRTXLGWIKSMO-UHFFFAOYSA-N (4-aminophenyl)sulfamic acid Chemical compound NC1=CC=C(NS(O)(=O)=O)C=C1 ZBTRTXLGWIKSMO-UHFFFAOYSA-N 0.000 description 1
- HQSMEHLVLOGBCK-UHFFFAOYSA-N 1-ethenylsulfinylethene Chemical compound C=CS(=O)C=C HQSMEHLVLOGBCK-UHFFFAOYSA-N 0.000 description 1
- QRIMLDXJAPZHJE-UHFFFAOYSA-N 2,3-dihydroxypropyl 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OCC(O)CO QRIMLDXJAPZHJE-UHFFFAOYSA-N 0.000 description 1
- JAHNSTQSQJOJLO-UHFFFAOYSA-N 2-(3-fluorophenyl)-1h-imidazole Chemical compound FC1=CC=CC(C=2NC=CN=2)=C1 JAHNSTQSQJOJLO-UHFFFAOYSA-N 0.000 description 1
- JKNCOURZONDCGV-UHFFFAOYSA-N 2-(dimethylamino)ethyl 2-methylprop-2-enoate Chemical compound CN(C)CCOC(=O)C(C)=C JKNCOURZONDCGV-UHFFFAOYSA-N 0.000 description 1
- XNWFRZJHXBZDAG-UHFFFAOYSA-N 2-METHOXYETHANOL Chemical compound COCCO XNWFRZJHXBZDAG-UHFFFAOYSA-N 0.000 description 1
- 125000000022 2-aminoethyl group Chemical group [H]C([*])([H])C([H])([H])N([H])[H] 0.000 description 1
- OMIGHNLMNHATMP-UHFFFAOYSA-N 2-hydroxyethyl prop-2-enoate Chemical compound OCCOC(=O)C=C OMIGHNLMNHATMP-UHFFFAOYSA-N 0.000 description 1
- XZIIFPSPUDAGJM-UHFFFAOYSA-N 6-chloro-2-n,2-n-diethylpyrimidine-2,4-diamine Chemical compound CCN(CC)C1=NC(N)=CC(Cl)=N1 XZIIFPSPUDAGJM-UHFFFAOYSA-N 0.000 description 1
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- 244000247812 Amorphophallus rivieri Species 0.000 description 1
- 235000001206 Amorphophallus rivieri Nutrition 0.000 description 1
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- 238000012935 Averaging Methods 0.000 description 1
- LCFVJGUPQDGYKZ-UHFFFAOYSA-N Bisphenol A diglycidyl ether Chemical compound C=1C=C(OCC2OC2)C=CC=1C(C)(C)C(C=C1)=CC=C1OCC1CO1 LCFVJGUPQDGYKZ-UHFFFAOYSA-N 0.000 description 1
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 description 1
- GAWIXWVDTYZWAW-UHFFFAOYSA-N C[CH]O Chemical group C[CH]O GAWIXWVDTYZWAW-UHFFFAOYSA-N 0.000 description 1
- GHXZTYHSJHQHIJ-UHFFFAOYSA-N Chlorhexidine Chemical compound C=1C=C(Cl)C=CC=1NC(N)=NC(N)=NCCCCCCN=C(N)N=C(N)NC1=CC=C(Cl)C=C1 GHXZTYHSJHQHIJ-UHFFFAOYSA-N 0.000 description 1
- 229920004934 Dacron® Polymers 0.000 description 1
- 229920002307 Dextran Polymers 0.000 description 1
- LCGLNKUTAGEVQW-UHFFFAOYSA-N Dimethyl ether Chemical compound COC LCGLNKUTAGEVQW-UHFFFAOYSA-N 0.000 description 1
- 102000016942 Elastin Human genes 0.000 description 1
- 108010014258 Elastin Proteins 0.000 description 1
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 1
- JIGUQPWFLRLWPJ-UHFFFAOYSA-N Ethyl acrylate Chemical compound CCOC(=O)C=C JIGUQPWFLRLWPJ-UHFFFAOYSA-N 0.000 description 1
- 239000005977 Ethylene Substances 0.000 description 1
- 240000001973 Ficus microcarpa Species 0.000 description 1
- 229920002581 Glucomannan Polymers 0.000 description 1
- 229920002907 Guar gum Polymers 0.000 description 1
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 1
- WOBHKFSMXKNTIM-UHFFFAOYSA-N Hydroxyethyl methacrylate Chemical compound CC(=C)C(=O)OCCO WOBHKFSMXKNTIM-UHFFFAOYSA-N 0.000 description 1
- 229920002752 Konjac Polymers 0.000 description 1
- CERQOIWHTDAKMF-UHFFFAOYSA-N Methacrylic acid Chemical compound CC(=C)C(O)=O CERQOIWHTDAKMF-UHFFFAOYSA-N 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 239000000020 Nitrocellulose Substances 0.000 description 1
- 206010061876 Obstruction Diseases 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 229930040373 Paraformaldehyde Natural products 0.000 description 1
- 229920002504 Poly(2-vinylpyridine-N-oxide) Polymers 0.000 description 1
- 229920002845 Poly(methacrylic acid) Polymers 0.000 description 1
- 229920002518 Polyallylamine hydrochloride Polymers 0.000 description 1
- 229920002614 Polyether block amide Polymers 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 229920002873 Polyethylenimine Polymers 0.000 description 1
- 229920001213 Polysorbate 20 Polymers 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 1
- 239000004373 Pullulan Substances 0.000 description 1
- 229920001218 Pullulan Polymers 0.000 description 1
- 206010040102 Seroma Diseases 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 238000010162 Tukey test Methods 0.000 description 1
- 206010047139 Vasoconstriction Diseases 0.000 description 1
- FJWGYAHXMCUOOM-QHOUIDNNSA-N [(2s,3r,4s,5r,6r)-2-[(2r,3r,4s,5r,6s)-4,5-dinitrooxy-2-(nitrooxymethyl)-6-[(2r,3r,4s,5r,6s)-4,5,6-trinitrooxy-2-(nitrooxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-3,5-dinitrooxy-6-(nitrooxymethyl)oxan-4-yl] nitrate Chemical compound O([C@@H]1O[C@@H]([C@H]([C@H](O[N+]([O-])=O)[C@H]1O[N+]([O-])=O)O[C@H]1[C@@H]([C@@H](O[N+]([O-])=O)[C@H](O[N+]([O-])=O)[C@@H](CO[N+]([O-])=O)O1)O[N+]([O-])=O)CO[N+](=O)[O-])[C@@H]1[C@@H](CO[N+]([O-])=O)O[C@@H](O[N+]([O-])=O)[C@H](O[N+]([O-])=O)[C@H]1O[N+]([O-])=O FJWGYAHXMCUOOM-QHOUIDNNSA-N 0.000 description 1
- WEXOBAIZDAHLOL-UHFFFAOYSA-N [I].C=Cc1ccccc1 Chemical compound [I].C=Cc1ccccc1 WEXOBAIZDAHLOL-UHFFFAOYSA-N 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 208000002223 abdominal aortic aneurysm Diseases 0.000 description 1
- DHKHKXVYLBGOIT-UHFFFAOYSA-N acetaldehyde Diethyl Acetal Natural products CCOC(C)OCC DHKHKXVYLBGOIT-UHFFFAOYSA-N 0.000 description 1
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 1
- 239000012190 activator Substances 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 229940072056 alginate Drugs 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- KPGABFJTMYCRHJ-YZOKENDUSA-N ammonium alginate Chemical class [NH4+].[NH4+].O1[C@@H](C([O-])=O)[C@@H](OC)[C@H](O)[C@H](O)[C@@H]1O[C@@H]1[C@@H](C([O-])=O)O[C@@H](O)[C@@H](O)[C@H]1O KPGABFJTMYCRHJ-YZOKENDUSA-N 0.000 description 1
- 230000033115 angiogenesis Effects 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 229940127219 anticoagulant drug Drugs 0.000 description 1
- 239000004599 antimicrobial Substances 0.000 description 1
- 210000002376 aorta thoracic Anatomy 0.000 description 1
- 208000007474 aortic aneurysm Diseases 0.000 description 1
- 229920006187 aquazol Polymers 0.000 description 1
- 239000012861 aquazol Substances 0.000 description 1
- 238000000149 argon plasma sintering Methods 0.000 description 1
- 239000011324 bead Substances 0.000 description 1
- KXHPPCXNWTUNSB-UHFFFAOYSA-M benzyl(trimethyl)azanium;chloride Chemical compound [Cl-].C[N+](C)(C)CC1=CC=CC=C1 KXHPPCXNWTUNSB-UHFFFAOYSA-M 0.000 description 1
- 210000000013 bile duct Anatomy 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 229920001222 biopolymer Polymers 0.000 description 1
- 229910000416 bismuth oxide Inorganic materials 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- CQEYYJKEWSMYFG-UHFFFAOYSA-N butyl acrylate Chemical compound CCCCOC(=O)C=C CQEYYJKEWSMYFG-UHFFFAOYSA-N 0.000 description 1
- 238000004422 calculation algorithm Methods 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 239000000679 carrageenan Substances 0.000 description 1
- 229920001525 carrageenan Polymers 0.000 description 1
- 229940113118 carrageenan Drugs 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 229920002301 cellulose acetate Polymers 0.000 description 1
- 229920003086 cellulose ether Polymers 0.000 description 1
- 239000000919 ceramic Substances 0.000 description 1
- 210000000038 chest Anatomy 0.000 description 1
- 229940045110 chitosan Drugs 0.000 description 1
- 229960003260 chlorhexidine Drugs 0.000 description 1
- XZQOHYZUWTWZBL-UHFFFAOYSA-L chromium(ii) bromide Chemical compound [Cr+2].[Br-].[Br-] XZQOHYZUWTWZBL-UHFFFAOYSA-L 0.000 description 1
- 230000015271 coagulation Effects 0.000 description 1
- 238000005345 coagulation Methods 0.000 description 1
- 238000004891 communication Methods 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- 238000004132 cross linking Methods 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 229960002086 dextran Drugs 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- TYIXMATWDRGMPF-UHFFFAOYSA-N dibismuth;oxygen(2-) Chemical compound [O-2].[O-2].[O-2].[Bi+3].[Bi+3] TYIXMATWDRGMPF-UHFFFAOYSA-N 0.000 description 1
- VAYGXNSJCAHWJZ-UHFFFAOYSA-N dimethyl sulfate Chemical compound COS(=O)(=O)OC VAYGXNSJCAHWJZ-UHFFFAOYSA-N 0.000 description 1
- 238000007598 dipping method Methods 0.000 description 1
- 239000004815 dispersion polymer Substances 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- NAIIFPOCIGMQBK-UHFFFAOYSA-N dodecyl-dimethyl-[2-(prop-2-enoylamino)ethyl]azanium;bromide Chemical compound [Br-].CCCCCCCCCCCC[N+](C)(C)CCNC(=O)C=C NAIIFPOCIGMQBK-UHFFFAOYSA-N 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 229920002549 elastin Polymers 0.000 description 1
- 210000003038 endothelium Anatomy 0.000 description 1
- YQGOJNYOYNNSMM-UHFFFAOYSA-N eosin Chemical compound [Na+].OC(=O)C1=CC=CC=C1C1=C2C=C(Br)C(=O)C(Br)=C2OC2=C(Br)C(O)=C(Br)C=C21 YQGOJNYOYNNSMM-UHFFFAOYSA-N 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 210000003238 esophagus Anatomy 0.000 description 1
- BYCHPAAGFQAEOD-UHFFFAOYSA-N ethenamine;hydrochloride Chemical compound Cl.NC=C BYCHPAAGFQAEOD-UHFFFAOYSA-N 0.000 description 1
- QHZOMAXECYYXGP-UHFFFAOYSA-N ethene;prop-2-enoic acid Chemical compound C=C.OC(=O)C=C QHZOMAXECYYXGP-UHFFFAOYSA-N 0.000 description 1
- FYUWIEKAVLOHSE-UHFFFAOYSA-N ethenyl acetate;1-ethenylpyrrolidin-2-one Chemical compound CC(=O)OC=C.C=CN1CCCC1=O FYUWIEKAVLOHSE-UHFFFAOYSA-N 0.000 description 1
- RTZKZFJDLAIYFH-UHFFFAOYSA-N ether Substances CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- 235000019325 ethyl cellulose Nutrition 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 238000001125 extrusion Methods 0.000 description 1
- 210000001105 femoral artery Anatomy 0.000 description 1
- 238000007380 fibre production Methods 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 239000007888 film coating Substances 0.000 description 1
- 239000000834 fixative Substances 0.000 description 1
- 238000002594 fluoroscopy Methods 0.000 description 1
- 239000012737 fresh medium Substances 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 229940046240 glucomannan Drugs 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- 150000002334 glycols Chemical class 0.000 description 1
- 239000000665 guar gum Substances 0.000 description 1
- 235000010417 guar gum Nutrition 0.000 description 1
- 229960002154 guar gum Drugs 0.000 description 1
- 210000003128 head Anatomy 0.000 description 1
- 210000003709 heart valve Anatomy 0.000 description 1
- 229960002897 heparin Drugs 0.000 description 1
- 229920000669 heparin Polymers 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 230000002706 hydrostatic effect Effects 0.000 description 1
- 230000002055 immunohistochemical effect Effects 0.000 description 1
- 238000003364 immunohistochemistry Methods 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 239000000252 konjac Substances 0.000 description 1
- 235000010485 konjac Nutrition 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000011068 loading method Methods 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 239000011976 maleic acid Substances 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- JZMJDSHXVKJFKW-UHFFFAOYSA-M methyl sulfate(1-) Chemical compound COS([O-])(=O)=O JZMJDSHXVKJFKW-UHFFFAOYSA-M 0.000 description 1
- XJRBAMWJDBPFIM-UHFFFAOYSA-N methyl vinyl ether Chemical group COC=C XJRBAMWJDBPFIM-UHFFFAOYSA-N 0.000 description 1
- LVHBHZANLOWSRM-UHFFFAOYSA-N methylenebutanedioic acid Natural products OC(=O)CC(=C)C(O)=O LVHBHZANLOWSRM-UHFFFAOYSA-N 0.000 description 1
- 238000000386 microscopy Methods 0.000 description 1
- 230000005012 migration Effects 0.000 description 1
- 238000013508 migration Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000000465 moulding Methods 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- HLXZNVUGXRDIFK-UHFFFAOYSA-N nickel titanium Chemical compound [Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni] HLXZNVUGXRDIFK-UHFFFAOYSA-N 0.000 description 1
- 229910001000 nickel titanium Inorganic materials 0.000 description 1
- 229920001220 nitrocellulos Polymers 0.000 description 1
- 238000010899 nucleation Methods 0.000 description 1
- 238000000424 optical density measurement Methods 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 239000006259 organic additive Substances 0.000 description 1
- 229920002866 paraformaldehyde Polymers 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- PNJWIWWMYCMZRO-UHFFFAOYSA-N pent‐4‐en‐2‐one Natural products CC(=O)CC=C PNJWIWWMYCMZRO-UHFFFAOYSA-N 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 229920002883 poly(2-hydroxypropyl methacrylate) Polymers 0.000 description 1
- 229920000885 poly(2-vinylpyridine) Polymers 0.000 description 1
- 229920000075 poly(4-vinylpyridine) Polymers 0.000 description 1
- 229920003213 poly(N-isopropyl acrylamide) Polymers 0.000 description 1
- 229920000371 poly(diallyldimethylammonium chloride) polymer Polymers 0.000 description 1
- 229920000172 poly(styrenesulfonic acid) Polymers 0.000 description 1
- 229920002432 poly(vinyl methyl ether) polymer Polymers 0.000 description 1
- 229920001798 poly[2-(acrylamido)-2-methyl-1-propanesulfonic acid] polymer Polymers 0.000 description 1
- 229920002401 polyacrylamide Polymers 0.000 description 1
- 229920000058 polyacrylate Polymers 0.000 description 1
- 239000004584 polyacrylic acid Substances 0.000 description 1
- 229920000767 polyaniline Polymers 0.000 description 1
- 229920000515 polycarbonate Polymers 0.000 description 1
- 239000004417 polycarbonate Substances 0.000 description 1
- 229920005646 polycarboxylate Polymers 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 229920001444 polymaleic acid Polymers 0.000 description 1
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 1
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 1
- 239000012196 polytetrafluoroethylene based material Substances 0.000 description 1
- 229920002717 polyvinylpyridine Polymers 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 239000013641 positive control Substances 0.000 description 1
- 238000009702 powder compression Methods 0.000 description 1
- 238000004663 powder metallurgy Methods 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 235000019423 pullulan Nutrition 0.000 description 1
- JUJWROOIHBZHMG-UHFFFAOYSA-O pyridinium Chemical compound C1=CC=[NH+]C=C1 JUJWROOIHBZHMG-UHFFFAOYSA-O 0.000 description 1
- 238000003908 quality control method Methods 0.000 description 1
- 210000002321 radial artery Anatomy 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 238000011552 rat model Methods 0.000 description 1
- 239000012925 reference material Substances 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000000241 respiratory effect Effects 0.000 description 1
- 208000037803 restenosis Diseases 0.000 description 1
- 238000013515 script Methods 0.000 description 1
- 238000009958 sewing Methods 0.000 description 1
- 238000007493 shaping process Methods 0.000 description 1
- 229910052709 silver Inorganic materials 0.000 description 1
- 239000004332 silver Substances 0.000 description 1
- 229940009188 silver Drugs 0.000 description 1
- 229960003600 silver sulfadiazine Drugs 0.000 description 1
- UEJSSZHHYBHCEL-UHFFFAOYSA-N silver(1+) sulfadiazinate Chemical compound [Ag+].C1=CC(N)=CC=C1S(=O)(=O)[N-]C1=NC=CC=N1 UEJSSZHHYBHCEL-UHFFFAOYSA-N 0.000 description 1
- BWYYYTVSBPRQCN-UHFFFAOYSA-M sodium;ethenesulfonate Chemical compound [Na+].[O-]S(=O)(=O)C=C BWYYYTVSBPRQCN-UHFFFAOYSA-M 0.000 description 1
- 229940035044 sorbitan monolaurate Drugs 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 238000004544 sputter deposition Methods 0.000 description 1
- 238000007655 standard test method Methods 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 230000003068 static effect Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 229910052715 tantalum Inorganic materials 0.000 description 1
- GUVRBAGPIYLISA-UHFFFAOYSA-N tantalum atom Chemical compound [Ta] GUVRBAGPIYLISA-UHFFFAOYSA-N 0.000 description 1
- 239000012815 thermoplastic material Substances 0.000 description 1
- 239000004416 thermosoftening plastic Substances 0.000 description 1
- 230000005944 tissue migration Effects 0.000 description 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
- USFMMZYROHDWPJ-UHFFFAOYSA-N trimethyl-[2-(2-methylprop-2-enoyloxy)ethyl]azanium Chemical compound CC(=C)C(=O)OCC[N+](C)(C)C USFMMZYROHDWPJ-UHFFFAOYSA-N 0.000 description 1
- 238000000108 ultra-filtration Methods 0.000 description 1
- 238000011144 upstream manufacturing Methods 0.000 description 1
- 230000025033 vasoconstriction Effects 0.000 description 1
- 230000024883 vasodilation Effects 0.000 description 1
- 230000035899 viability Effects 0.000 description 1
- ZTWTYVWXUKTLCP-UHFFFAOYSA-N vinylphosphonic acid Chemical compound OP(O)(=O)C=C ZTWTYVWXUKTLCP-UHFFFAOYSA-N 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
Images
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B32—LAYERED PRODUCTS
- B32B—LAYERED PRODUCTS, i.e. PRODUCTS BUILT-UP OF STRATA OF FLAT OR NON-FLAT, e.g. CELLULAR OR HONEYCOMB, FORM
- B32B38/00—Ancillary operations in connection with laminating processes
- B32B38/0036—Heat treatment
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/04—Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
- A61F2/06—Blood vessels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/04—Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
- A61F2/06—Blood vessels
- A61F2/07—Stent-grafts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/852—Two or more distinct overlapping stents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
- A61F2/88—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure the wire-like elements formed as helical or spiral coils
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/28—Materials for coating prostheses
- A61L27/34—Macromolecular materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/56—Porous materials, e.g. foams or sponges
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/08—Materials for coatings
- A61L31/10—Macromolecular materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L31/146—Porous materials, e.g. foams or sponges
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B05—SPRAYING OR ATOMISING IN GENERAL; APPLYING FLUENT MATERIALS TO SURFACES, IN GENERAL
- B05D—PROCESSES FOR APPLYING FLUENT MATERIALS TO SURFACES, IN GENERAL
- B05D1/00—Processes for applying liquids or other fluent materials
- B05D1/002—Processes for applying liquids or other fluent materials the substrate being rotated
- B05D1/005—Spin coating
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09D—COATING COMPOSITIONS, e.g. PAINTS, VARNISHES OR LACQUERS; FILLING PASTES; CHEMICAL PAINT OR INK REMOVERS; INKS; CORRECTING FLUIDS; WOODSTAINS; PASTES OR SOLIDS FOR COLOURING OR PRINTING; USE OF MATERIALS THEREFOR
- C09D127/00—Coating compositions based on homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by a halogen; Coating compositions based on derivatives of such polymers
- C09D127/02—Coating compositions based on homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by a halogen; Coating compositions based on derivatives of such polymers not modified by chemical after-treatment
- C09D127/12—Coating compositions based on homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by a halogen; Coating compositions based on derivatives of such polymers not modified by chemical after-treatment containing fluorine atoms
- C09D127/18—Homopolymers or copolymers of tetrafluoroethene
-
- D—TEXTILES; PAPER
- D01—NATURAL OR MAN-MADE THREADS OR FIBRES; SPINNING
- D01D—MECHANICAL METHODS OR APPARATUS IN THE MANUFACTURE OF ARTIFICIAL FILAMENTS, THREADS, FIBRES, BRISTLES OR RIBBONS
- D01D5/00—Formation of filaments, threads, or the like
- D01D5/18—Formation of filaments, threads, or the like by means of rotating spinnerets
-
- D—TEXTILES; PAPER
- D01—NATURAL OR MAN-MADE THREADS OR FIBRES; SPINNING
- D01F—CHEMICAL FEATURES IN THE MANUFACTURE OF ARTIFICIAL FILAMENTS, THREADS, FIBRES, BRISTLES OR RIBBONS; APPARATUS SPECIALLY ADAPTED FOR THE MANUFACTURE OF CARBON FILAMENTS
- D01F6/00—Monocomponent artificial filaments or the like of synthetic polymers; Manufacture thereof
- D01F6/02—Monocomponent artificial filaments or the like of synthetic polymers; Manufacture thereof from homopolymers obtained by reactions only involving carbon-to-carbon unsaturated bonds
- D01F6/08—Monocomponent artificial filaments or the like of synthetic polymers; Manufacture thereof from homopolymers obtained by reactions only involving carbon-to-carbon unsaturated bonds from polymers of halogenated hydrocarbons
- D01F6/12—Monocomponent artificial filaments or the like of synthetic polymers; Manufacture thereof from homopolymers obtained by reactions only involving carbon-to-carbon unsaturated bonds from polymers of halogenated hydrocarbons from polymers of fluorinated hydrocarbons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/0077—Special surfaces of prostheses, e.g. for improving ingrowth
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
- A61F2/89—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure the wire-like elements comprising two or more adjacent rings flexibly connected by separate members
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/04—Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
- A61F2/06—Blood vessels
- A61F2002/065—Y-shaped blood vessels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/04—Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
- A61F2/06—Blood vessels
- A61F2/07—Stent-grafts
- A61F2002/072—Encapsulated stents, e.g. wire or whole stent embedded in lining
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/04—Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
- A61F2/06—Blood vessels
- A61F2/07—Stent-grafts
- A61F2002/075—Stent-grafts the stent being loosely attached to the graft material, e.g. by stitching
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2210/00—Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2210/0076—Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof multilayered, e.g. laminated structures
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2230/00—Geometry of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2230/0002—Two-dimensional shapes, e.g. cross-sections
- A61F2230/0028—Shapes in the form of latin or greek characters
- A61F2230/005—Rosette-shaped, e.g. star-shaped
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2420/00—Materials or methods for coatings medical devices
- A61L2420/02—Methods for coating medical devices
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2420/00—Materials or methods for coatings medical devices
- A61L2420/08—Coatings comprising two or more layers
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B32—LAYERED PRODUCTS
- B32B—LAYERED PRODUCTS, i.e. PRODUCTS BUILT-UP OF STRATA OF FLAT OR NON-FLAT, e.g. CELLULAR OR HONEYCOMB, FORM
- B32B2255/00—Coating on the layer surface
- B32B2255/10—Coating on the layer surface on synthetic resin layer or on natural or synthetic rubber layer
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Transplantation (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Epidemiology (AREA)
- Cardiology (AREA)
- Medicinal Chemistry (AREA)
- Textile Engineering (AREA)
- Dispersion Chemistry (AREA)
- Dermatology (AREA)
- Surgery (AREA)
- Pulmonology (AREA)
- Gastroenterology & Hepatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Mechanical Engineering (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Materials Engineering (AREA)
- Wood Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Thermal Sciences (AREA)
- Materials For Medical Uses (AREA)
- Prostheses (AREA)
- Polymers & Plastics (AREA)
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261587088P | 2012-01-16 | 2012-01-16 | |
| US61/587,088 | 2012-01-16 | ||
| US201261637693P | 2012-04-24 | 2012-04-24 | |
| US61/637,693 | 2012-04-24 | ||
| US201261672633P | 2012-07-17 | 2012-07-17 | |
| US61/672,633 | 2012-07-17 | ||
| PCT/US2013/021554 WO2013109528A1 (en) | 2012-01-16 | 2013-01-15 | Rotational spun material covered medical appliances and methods of manufacture |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| KR20140121822A KR20140121822A (ko) | 2014-10-16 |
| KR102037543B1 true KR102037543B1 (ko) | 2019-10-28 |
Family
ID=48780521
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1020147019313A Active KR102037543B1 (ko) | 2012-01-16 | 2013-01-15 | 회전 방사 재료로 커버링된 의료 기구 및 제조 방법 |
Country Status (10)
| Country | Link |
|---|---|
| US (11) | US9987833B2 (enExample) |
| EP (2) | EP2804637B1 (enExample) |
| JP (1) | JP6300732B2 (enExample) |
| KR (1) | KR102037543B1 (enExample) |
| CN (2) | CN110064076A (enExample) |
| AU (1) | AU2013209965B2 (enExample) |
| BR (1) | BR112014016892B1 (enExample) |
| CA (1) | CA2856305C (enExample) |
| DK (1) | DK2804637T3 (enExample) |
| WO (1) | WO2013109528A1 (enExample) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2023277264A1 (ko) * | 2021-06-30 | 2023-01-05 | (재)예수병원유지재단 | 스텐트 그래프트 |
Families Citing this family (86)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2240215B1 (en) * | 2008-01-17 | 2014-01-08 | Boston Scientific Scimed, Inc. | Stent with anti-migration feature |
| DK2384375T3 (en) | 2009-01-16 | 2017-10-16 | Zeus Ind Products Inc | ELECTROSPINING PTFE WITH HIGH-VISUAL MATERIALS |
| US20130268062A1 (en) | 2012-04-05 | 2013-10-10 | Zeus Industrial Products, Inc. | Composite prosthetic devices |
| US8151682B2 (en) | 2009-01-26 | 2012-04-10 | Boston Scientific Scimed, Inc. | Atraumatic stent and method and apparatus for making the same |
| CN102470030A (zh) | 2009-08-07 | 2012-05-23 | 宙斯工业产品股份有限公司 | 包含静电纺纤维层的假体装置及其制备方法 |
| WO2012103501A1 (en) | 2011-01-28 | 2012-08-02 | Merit Medical Systems, Inc. | Electrospun ptfe coated stent and method of use |
| US8986368B2 (en) | 2011-10-31 | 2015-03-24 | Merit Medical Systems, Inc. | Esophageal stent with valve |
| AU2013209965B2 (en) | 2012-01-16 | 2016-06-30 | Merit Medical Systems, Inc. | Rotational spun material covered medical appliances and methods of manufacture |
| US9775933B2 (en) | 2012-03-02 | 2017-10-03 | W. L. Gore & Associates, Inc. | Biocompatible surfaces and devices incorporating such surfaces |
| US9526640B2 (en) * | 2013-08-18 | 2016-12-27 | Boston Scientific Scimed, Inc. | Anti-migration micropatterned stent coating |
| US9681975B2 (en) | 2012-05-31 | 2017-06-20 | Valentx, Inc. | Devices and methods for gastrointestinal bypass |
| US20130324906A1 (en) | 2012-05-31 | 2013-12-05 | Valen Tx, Inc. | Devices and methods for gastrointestinal bypass |
| US8956318B2 (en) | 2012-05-31 | 2015-02-17 | Valentx, Inc. | Devices and methods for gastrointestinal bypass |
| US11541154B2 (en) * | 2012-09-19 | 2023-01-03 | Merit Medical Systems, Inc. | Electrospun material covered medical appliances and methods of manufacture |
| US9198999B2 (en) * | 2012-09-21 | 2015-12-01 | Merit Medical Systems, Inc. | Drug-eluting rotational spun coatings and methods of use |
| US20140188245A1 (en) * | 2012-12-22 | 2014-07-03 | Valentx, Inc. | Devices for gastrointestinal bypass having tissue ingrowth features |
| HK1217663A1 (zh) * | 2013-01-09 | 2017-01-20 | Harvard Apparatus Regenerative Technology, Inc. | 合成支架 |
| WO2014159710A1 (en) | 2013-03-13 | 2014-10-02 | Merit Medical Systems, Inc. | Serially deposited fiber materials and associated devices and methods |
| US9757264B2 (en) | 2013-03-13 | 2017-09-12 | Valentx, Inc. | Devices and methods for gastrointestinal bypass |
| US9827703B2 (en) | 2013-03-13 | 2017-11-28 | Merit Medical Systems, Inc. | Methods, systems, and apparatuses for manufacturing rotational spun appliances |
| WO2014143730A1 (en) * | 2013-03-15 | 2014-09-18 | Boston Scientific Scimed, Inc. | Anti-migratory stent coating |
| EP3027124B1 (en) | 2013-07-31 | 2022-01-12 | Embolic Acceleration, LLC | Devices for endovascular embolization |
| US10010328B2 (en) | 2013-07-31 | 2018-07-03 | NeuVT Limited | Endovascular occlusion device with hemodynamically enhanced sealing and anchoring |
| US9700401B2 (en) | 2013-09-12 | 2017-07-11 | Boston Scientific Scimed, Inc. | Stent with anti-migration connectors |
| CN103598939A (zh) * | 2013-10-17 | 2014-02-26 | 杭州启明医疗器械有限公司 | 提高安全性的肺动脉支架及肺动脉瓣膜置换装置 |
| EP3119354B1 (en) | 2014-03-18 | 2018-06-06 | Boston Scientific Scimed, Inc. | Reduced granulation and inflammation stent design |
| DE102014109769B4 (de) * | 2014-07-11 | 2018-05-24 | Gottfried Wilhelm Leibniz Universität Hannover | Einrichtung und Verfahren zur Herstellung einer Gefäßprothese |
| KR101493485B1 (ko) | 2014-07-29 | 2015-02-16 | 김정권 | 스텐트 및 이의 제조방법 |
| EP3197515A1 (en) * | 2014-09-23 | 2017-08-02 | Boston Scientific Scimed Inc. | Implantable medical device with shape memory polymer filter layer |
| WO2016054536A1 (en) | 2014-10-02 | 2016-04-07 | Boston Scientific Scimed, Inc. | Controlled ingrowth feature for antimigration |
| CN107106310B (zh) | 2014-10-22 | 2019-03-22 | 波士顿科学国际有限公司 | 具有柔性铰链的支架 |
| WO2016065084A1 (en) | 2014-10-22 | 2016-04-28 | Boston Scientific Scimed, Inc. | Controlled tissue ingrowth stent covering |
| US20160128852A1 (en) | 2014-11-06 | 2016-05-12 | Boston Scientific Scimed, Inc. | Tracheal stent |
| CN104490502A (zh) * | 2014-12-25 | 2015-04-08 | 周玉杰 | 一种用于治疗冠脉穿孔的生物可吸收膜覆膜支架 |
| CA3285239A1 (en) * | 2015-02-26 | 2025-11-29 | Merit Medical Systems Inc | Layered medical appliances and methods |
| US10463470B2 (en) * | 2015-07-31 | 2019-11-05 | Cook Medical Technologies Llc | Methods of making a prosthesis with a smooth covering |
| US20170086993A1 (en) * | 2015-09-30 | 2017-03-30 | Cook Medical Technologies Llc | Modular system with at least one branch graft |
| WO2017062740A1 (en) | 2015-10-09 | 2017-04-13 | EMBA Medical Limited | Endovascular occlusion device with hemodynamically enhanced sealing and anchoring |
| US20190046696A1 (en) * | 2016-03-11 | 2019-02-14 | The Johns Hopkins University | Partially degradable stents for controlled reduction of intraocular pressure |
| EP3484568B2 (en) | 2016-07-13 | 2025-07-16 | Perfuze Limited | High flexibility, kink resistant catheter shaft |
| CN108066047B (zh) * | 2016-11-15 | 2020-06-30 | 先健科技(深圳)有限公司 | 阻流膜及植入医疗器械 |
| CN108245278B (zh) * | 2016-12-28 | 2020-12-18 | 先健科技(深圳)有限公司 | 覆膜支架 |
| WO2018156849A1 (en) | 2017-02-24 | 2018-08-30 | Bolton Medical, Inc. | Vascular prosthesis with fenestration ring and methods of use |
| JP7065091B2 (ja) | 2017-02-24 | 2022-05-11 | ボルトン メディカル インコーポレイテッド | 半径方向に調整可能なステントグラフト送達システム |
| WO2018156850A1 (en) | 2017-02-24 | 2018-08-30 | Bolton Medical, Inc. | Stent graft with fenestration lock |
| WO2018156852A1 (en) | 2017-02-24 | 2018-08-30 | Bolton Medical, Inc. | Stent graft delivery system with constricted sheath and method of use |
| ES2927219T5 (en) | 2017-02-24 | 2025-11-06 | Bolton Medical Inc | Delivery system for radially constricting a stent graft |
| WO2018156851A1 (en) | 2017-02-24 | 2018-08-30 | Bolton Medical, Inc. | Vascular prosthesis with moveable fenestration |
| WO2018156848A1 (en) | 2017-02-24 | 2018-08-30 | Bolton Medical, Inc. | Vascular prosthesis with crimped adapter and methods of use |
| ES2863978T3 (es) | 2017-02-24 | 2021-10-13 | Bolton Medical Inc | Sistema para constreñir radialmente un injerto de stent |
| WO2018156847A1 (en) | 2017-02-24 | 2018-08-30 | Bolton Medical, Inc. | Delivery system and method to radially constrict a stent graft |
| EP3534837A1 (en) | 2017-02-24 | 2019-09-11 | Bolton Medical, Inc. | Constrainable stent graft, delivery system and methods of use |
| US11351058B2 (en) | 2017-03-17 | 2022-06-07 | W. L. Gore & Associates, Inc. | Glaucoma treatment systems and methods |
| GB201717885D0 (en) * | 2017-10-31 | 2017-12-13 | Hothouse Medical Ltd | Prothesis and method of manufacture |
| EP3558175B1 (en) | 2017-10-31 | 2022-01-12 | Bolton Medical, Inc. | Distal torque component, delivery system and method of using same |
| CN108295316B (zh) * | 2018-03-08 | 2021-03-26 | 戴庆涛 | 一种肠道支架及其制作方法 |
| WO2020047222A1 (en) * | 2018-08-29 | 2020-03-05 | W. L. Gore & Associates, Inc. | Ocular drainage system devices and methods |
| AU2019333136B2 (en) | 2018-08-29 | 2022-11-17 | W. L. Gore & Associates, Inc. | Drug therapy delivery systems and methods |
| US11278391B2 (en) | 2018-08-30 | 2022-03-22 | Cook Medical Technologies Llc | Graft having at least one woven taper |
| CN109172037B (zh) * | 2018-10-22 | 2023-09-12 | 上海交通大学医学院附属上海儿童医学中心 | 一种基于3d打印和静电纺丝技术的复层组织工程气管支架的设计及应用 |
| CN111096823B (zh) * | 2018-10-25 | 2022-01-18 | 深圳市先健畅通医疗有限公司 | 覆膜支架 |
| WO2020150558A1 (en) * | 2019-01-18 | 2020-07-23 | W. L. Gore & Associates, Inc. | Bioabsorbable filament medical devices |
| US11690705B2 (en) | 2019-03-15 | 2023-07-04 | Cook Medical Technologies Llc | Graft having a pocket for receiving a stent and woven graft material, forming a pocket |
| US11707351B2 (en) | 2019-08-19 | 2023-07-25 | Encompass Technologies, Inc. | Embolic protection and access system |
| JP7508551B2 (ja) | 2019-10-29 | 2024-07-01 | ボストン サイエンティフィック サイムド,インコーポレイテッド | ずれ防止機能を有するステント |
| CN111005082A (zh) * | 2019-12-17 | 2020-04-14 | 东华大学 | 一种通体多孔聚己内酯纤维及其制备方法 |
| EP4090296A1 (en) | 2020-01-13 | 2022-11-23 | Boston Scientific Scimed Inc. | Anti-migration stent |
| CN111249032B (zh) * | 2020-01-18 | 2021-09-07 | 中国人民解放军陆军军医大学第一附属医院 | 腹动脉重塑装置 |
| CN111388763B (zh) * | 2020-03-25 | 2021-12-10 | 南通纺织丝绸产业技术研究院 | 基于ptfe的血管支架的制备方法及其应用 |
| US11969335B2 (en) | 2020-04-28 | 2024-04-30 | Cook Medical Technologies Llc | Woven graft having a taper with a re-engaged warp end |
| CN111821065B (zh) * | 2020-06-01 | 2021-11-16 | 北京爱霖医疗科技有限公司 | 一种覆膜植入物的制备方法 |
| KR20230087528A (ko) * | 2020-10-12 | 2023-06-16 | 어센스 메디컬 게엠베하 | 혈관 스텐트 그래프트 |
| WO2022183215A1 (en) * | 2021-02-26 | 2022-09-01 | Merit Medical Systems, Inc. | Fibrous constructs with therapeutic material particles |
| CN113017914B (zh) * | 2021-03-17 | 2023-07-04 | 复旦大学附属中山医院 | 一种防止覆膜支架出入口内膜增生的外周血管复合支架 |
| CN113151980A (zh) * | 2021-03-19 | 2021-07-23 | 苏州大学 | Ptfe管状覆膜支架及其制备方法 |
| CN113398325B (zh) * | 2021-06-11 | 2023-04-21 | 叶川 | 用于增强螺钉稳定性和诱导骨再生的纤维膜及其制备方法 |
| EP4380511A4 (en) * | 2021-08-02 | 2025-05-28 | Merit Medical Systems, Inc. | CORONARY STENT |
| US11589975B1 (en) * | 2021-08-30 | 2023-02-28 | Bipore Medical Devices, Inc. | Small diameter vascular prosthesis |
| WO2023044055A1 (en) * | 2021-09-17 | 2023-03-23 | President And Fellows Of Harvard College | Biodegradable and bioactive fibers, scaffolds, and methods of use thereof |
| US11957356B2 (en) | 2022-02-24 | 2024-04-16 | NV MEDTECH, Inc. | Methods and apparatus for stent assisted aneurysm coiling |
| WO2024111961A2 (ko) * | 2022-11-23 | 2024-05-30 | 강성권 | 다층 피복 혈관 스텐트 및 이것의 제조 방법 |
| CN116211379B (zh) * | 2023-05-06 | 2023-08-15 | 上海暖阳医疗器械有限公司 | 一种覆膜栓塞支架和覆膜工艺 |
| US20250001052A1 (en) * | 2023-06-27 | 2025-01-02 | Zeus Company Llc | Coated eptfe liners for catheters |
| CN116899030B (zh) * | 2023-06-29 | 2025-08-01 | 江苏百优达生命科技有限公司 | 一种不掉纤维的医用垫片及其制备方法 |
| CN117297835B (zh) * | 2023-11-28 | 2024-02-06 | 上海宏普医疗器械有限公司 | 一种可穿刺覆膜支架 |
| WO2025184560A1 (en) * | 2024-03-01 | 2025-09-04 | Merit Medical Systems, Inc. | Layered medical appliances and methods |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20090280325A1 (en) * | 2008-03-17 | 2009-11-12 | Karen Lozano | Methods and apparatuses for making superfine fibers |
| WO2011017698A1 (en) * | 2009-08-07 | 2011-02-10 | Zeus, Inc. | Prosthetic device including electrostatically spun fibrous layer and method for making the same |
Family Cites Families (195)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2772444A (en) | 1954-08-12 | 1956-12-04 | Du Pont | Composition comprising a polyhalogenated ethylene polymer and viscose and process of shaping the same |
| US3047444A (en) | 1955-07-15 | 1962-07-31 | Kimberly Clark Co | Non-woven fabric and method of making the same |
| US3203365A (en) | 1962-06-21 | 1965-08-31 | Bowe John | Cotton candy spinning machine |
| JPS5140476B1 (enExample) | 1968-07-31 | 1976-11-04 | ||
| US4096227A (en) * | 1973-07-03 | 1978-06-20 | W. L. Gore & Associates, Inc. | Process for producing filled porous PTFE products |
| GB1527592A (en) | 1974-08-05 | 1978-10-04 | Ici Ltd | Wound dressing |
| GB1522605A (en) | 1974-09-26 | 1978-08-23 | Ici Ltd | Preparation of fibrous sheet product |
| US6436135B1 (en) | 1974-10-24 | 2002-08-20 | David Goldfarb | Prosthetic vascular graft |
| EP0005035B1 (en) | 1978-04-19 | 1981-09-23 | Imperial Chemical Industries Plc | A method of preparing a tubular product by electrostatic spinning |
| US4223101A (en) | 1978-07-17 | 1980-09-16 | Inmont Corporation | Method of producing fibrous structure |
| EP0009941B2 (en) | 1978-10-10 | 1987-05-27 | Imperial Chemical Industries Plc | Production of electrostatically spun products |
| DE2965756D1 (en) | 1978-11-20 | 1983-07-28 | Ici Plc | A process for setting a product comprising electrostatically spun fibres, and products prepared according to this process |
| GB2121286B (en) | 1982-06-02 | 1985-11-06 | Ethicon Inc | Improvements in synthetic vascular grafts, and methods of manufacturing such grafts |
| US5162074A (en) | 1987-10-02 | 1992-11-10 | Basf Corporation | Method of making plural component fibers |
| AT391473B (de) | 1989-04-06 | 1990-10-10 | Chemiefaser Lenzing Ag | Monoaxial verstreckter formkoerper aus polytetrafluoraethylen und verfahren zu seiner herstellung |
| AU7524391A (en) | 1990-05-15 | 1991-11-21 | C.R. Bard Inc. | Multiple layer high strength balloon for dilatation catheter |
| US5236447A (en) | 1990-06-29 | 1993-08-17 | Nissho Corporation | Artificial tubular organ |
| US5328946A (en) | 1991-08-29 | 1994-07-12 | E. I. Du Pont De Nemours And Company | Solvents for tetrafluoroethylene polymers |
| DE4130356C2 (de) | 1991-09-12 | 1995-01-26 | Bitterfeld Wolfen Chemie | Fasermaterial aus PTFE und Verfahren zu seiner Herstellung |
| US5512051A (en) | 1993-02-16 | 1996-04-30 | Boston Scientific Corporation | Slip-layered catheter balloon |
| JP3079571B2 (ja) | 1993-04-05 | 2000-08-21 | ダイキン工業株式会社 | ポリテトラフルオロエチレン繊維,それを含む綿状物およびその製造方法 |
| ATE230243T1 (de) | 1993-07-12 | 2003-01-15 | Univ California | Verstärkungsvorrichtung für weiches gewebe |
| JPH09501585A (ja) * | 1993-08-18 | 1997-02-18 | ダブリュ.エル.ゴア アンド アソシエイツ,インコーポレイティド | 薄肉でシームレスの多孔質ポリテトラフルオロエチレンチューブ |
| US5735892A (en) | 1993-08-18 | 1998-04-07 | W. L. Gore & Associates, Inc. | Intraluminal stent graft |
| US5723004A (en) | 1993-10-21 | 1998-03-03 | Corvita Corporation | Expandable supportive endoluminal grafts |
| EP0744968A1 (en) | 1994-02-17 | 1996-12-04 | W.L. Gore & Associates, Inc. | A carvable ptfe implant material |
| US5509902A (en) | 1994-07-25 | 1996-04-23 | Raulerson; J. Daniel | Subcutaneous catheter stabilizing devices and methods for securing a catheter using the same |
| US6451047B2 (en) | 1995-03-10 | 2002-09-17 | Impra, Inc. | Encapsulated intraluminal stent-graft and methods of making same |
| BE1009278A3 (fr) | 1995-04-12 | 1997-01-07 | Corvita Europ | Tuteur auto-expansible pour dispositif medical a introduire dans une cavite d'un corps, et dispositif medical muni d'un tel tuteur. |
| US5552100A (en) | 1995-05-02 | 1996-09-03 | Baxter International Inc. | Method for manufacturing porous fluoropolymer films |
| US5665428A (en) | 1995-10-25 | 1997-09-09 | Macromed, Inc. | Preparation of peptide containing biodegradable microspheres by melt process |
| US5702658A (en) | 1996-02-29 | 1997-12-30 | Owens-Corning Fiberglas Technology, Inc. | Bicomponent polymer fibers made by rotary process |
| US5922021A (en) * | 1996-04-26 | 1999-07-13 | Jang; G. David | Intravascular stent |
| US5928279A (en) | 1996-07-03 | 1999-07-27 | Baxter International Inc. | Stented, radially expandable, tubular PTFE grafts |
| US6010529A (en) | 1996-12-03 | 2000-01-04 | Atrium Medical Corporation | Expandable shielded vessel support |
| US6015431A (en) * | 1996-12-23 | 2000-01-18 | Prograft Medical, Inc. | Endolumenal stent-graft with leak-resistant seal |
| EP0884029B1 (en) | 1997-06-13 | 2004-12-22 | Gary J. Becker | Expandable intraluminal endoprosthesis |
| US6106913A (en) | 1997-10-10 | 2000-08-22 | Quantum Group, Inc | Fibrous structures containing nanofibrils and other textile fibers |
| WO1999018893A1 (en) | 1997-10-10 | 1999-04-22 | Drexel University | Hybrid nanofibril matrices for use as tissue engineering devices |
| EP1359194B1 (en) | 1998-02-24 | 2006-10-11 | Asahi Glass Company, Limited | Polytetrafluoroethylene aqueous dispersion composition |
| EP0950421B1 (en) | 1998-04-14 | 2006-10-18 | Tranquil Prospects Ltd. | Implantable material and method for its preparation |
| US6156064A (en) * | 1998-08-14 | 2000-12-05 | Schneider (Usa) Inc | Stent-graft-membrane and method of making the same |
| US6336937B1 (en) | 1998-12-09 | 2002-01-08 | Gore Enterprise Holdings, Inc. | Multi-stage expandable stent-graft |
| US6517571B1 (en) | 1999-01-22 | 2003-02-11 | Gore Enterprise Holdings, Inc. | Vascular graft with improved flow surfaces |
| ATE326197T1 (de) * | 1999-01-22 | 2006-06-15 | Gore Enterprise Holdings Inc | Ummantelte endoprothese |
| AU768150B2 (en) | 1999-01-22 | 2003-12-04 | W.L. Gore & Associates, Inc. | A biliary stent-graft |
| US7018401B1 (en) | 1999-02-01 | 2006-03-28 | Board Of Regents, The University Of Texas System | Woven intravascular devices and methods for making the same and apparatus for delivery of the same |
| US20020090725A1 (en) | 2000-11-17 | 2002-07-11 | Simpson David G. | Electroprocessed collagen |
| US6248122B1 (en) | 1999-02-26 | 2001-06-19 | Vascular Architects, Inc. | Catheter with controlled release endoluminal prosthesis |
| US6364903B2 (en) | 1999-03-19 | 2002-04-02 | Meadox Medicals, Inc. | Polymer coated stent |
| US6306424B1 (en) | 1999-06-30 | 2001-10-23 | Ethicon, Inc. | Foam composite for the repair or regeneration of tissue |
| US6652570B2 (en) | 1999-07-02 | 2003-11-25 | Scimed Life Systems, Inc. | Composite vascular graft |
| US7947069B2 (en) | 1999-11-24 | 2011-05-24 | University Of Washington | Medical devices comprising small fiber biomaterials, and methods of use |
| US6942688B2 (en) | 2000-02-29 | 2005-09-13 | Cordis Corporation | Stent delivery system having delivery catheter member with a clear transition zone |
| US7300662B2 (en) | 2000-05-12 | 2007-11-27 | Cordis Corporation | Drug/drug delivery systems for the prevention and treatment of vascular disease |
| US20020077693A1 (en) | 2000-12-19 | 2002-06-20 | Barclay Bruce J. | Covered, coiled drug delivery stent and method |
| AU2001286731A1 (en) | 2000-08-25 | 2002-03-04 | Kensey Nash Corporation | Covered stents, systems for deploying covered stents |
| US7416559B2 (en) | 2000-10-27 | 2008-08-26 | Poly-Med, Inc. | Micromantled drug-eluting stent |
| US7244272B2 (en) | 2000-12-19 | 2007-07-17 | Nicast Ltd. | Vascular prosthesis and method for production thereof |
| US20020084178A1 (en) | 2000-12-19 | 2002-07-04 | Nicast Corporation Ltd. | Method and apparatus for manufacturing polymer fiber shells via electrospinning |
| US20070031607A1 (en) | 2000-12-19 | 2007-02-08 | Alexander Dubson | Method and apparatus for coating medical implants |
| US20040030377A1 (en) | 2001-10-19 | 2004-02-12 | Alexander Dubson | Medicated polymer-coated stent assembly |
| US6673105B1 (en) * | 2001-04-02 | 2004-01-06 | Advanced Cardiovascular Systems, Inc. | Metal prosthesis coated with expandable ePTFE |
| US7510571B2 (en) | 2001-06-11 | 2009-03-31 | Boston Scientific, Scimed, Inc. | Pleated composite ePTFE/textile hybrid covering |
| US6863678B2 (en) | 2001-09-19 | 2005-03-08 | Advanced Cardiovascular Systems, Inc. | Catheter with a multilayered shaft section having a polyimide layer |
| EP2319453B1 (en) | 2001-09-28 | 2016-07-20 | Boston Scientific Limited | A cardiovascular balloon catheter comprising nanocomposites |
| US20030100944A1 (en) | 2001-11-28 | 2003-05-29 | Olga Laksin | Vascular graft having a chemicaly bonded electrospun fibrous layer and method for making same |
| US6752826B2 (en) | 2001-12-14 | 2004-06-22 | Thoratec Corporation | Layered stent-graft and methods of making the same |
| US6911040B2 (en) | 2002-01-24 | 2005-06-28 | Cordis Corporation | Covered segmented stent |
| JP4332329B2 (ja) | 2002-02-26 | 2009-09-16 | 三菱レイヨン株式会社 | 中空糸膜モジュールの製造装置並びに製造方法 |
| US20050187605A1 (en) | 2002-04-11 | 2005-08-25 | Greenhalgh Skott E. | Electrospun skin capable of controlling drug release rates and method |
| US20030195611A1 (en) | 2002-04-11 | 2003-10-16 | Greenhalgh Skott E. | Covering and method using electrospinning of very small fibers |
| US20030211135A1 (en) | 2002-04-11 | 2003-11-13 | Greenhalgh Skott E. | Stent having electrospun covering and method |
| US20040051201A1 (en) | 2002-04-11 | 2004-03-18 | Greenhalgh Skott E. | Coated stent and method for coating by treating an electrospun covering with heat or chemicals |
| US7485141B2 (en) | 2002-05-10 | 2009-02-03 | Cordis Corporation | Method of placing a tubular membrane on a structural frame |
| JP2004028261A (ja) | 2002-06-27 | 2004-01-29 | Fuji Koki Corp | 膨張弁 |
| US7550004B2 (en) | 2002-08-20 | 2009-06-23 | Cook Biotech Incorporated | Endoluminal device with extracellular matrix material and methods |
| US6833178B2 (en) | 2002-08-22 | 2004-12-21 | Compagnie Plastic Omnium | Multilayer laminated structure, in particular for wrapping electric cables |
| US8337937B2 (en) | 2002-09-30 | 2012-12-25 | Abbott Cardiovascular Systems Inc. | Stent spin coating method |
| US7025791B2 (en) | 2002-12-02 | 2006-04-11 | Gi Dynamics, Inc. | Bariatric sleeve |
| CN100429336C (zh) | 2003-04-03 | 2008-10-29 | 纳幕尔杜邦公司 | 形成均匀材料的旋转法 |
| US7524527B2 (en) | 2003-05-19 | 2009-04-28 | Boston Scientific Scimed, Inc. | Electrostatic coating of a device |
| US7574526B2 (en) * | 2003-07-31 | 2009-08-11 | International Business Machines Corporation | Multicast group management in infiniband |
| WO2005018600A2 (en) | 2003-08-22 | 2005-03-03 | Cube Medical A/S | Method of treating a patient suffering from a solid tumour |
| US20050053782A1 (en) | 2003-09-04 | 2005-03-10 | Ayusman Sen | Process for forming polymeric micro and nanofibers |
| JP2007508121A (ja) | 2003-10-14 | 2007-04-05 | キューブ メディカル エーエス | 血管形成術用バルーン |
| BRPI0417659A (pt) | 2003-12-18 | 2007-04-03 | Procter & Gamble | processos de fiação giratória para a formação de fibras contendo polìmero de hidroxila |
| US7803178B2 (en) | 2004-01-30 | 2010-09-28 | Trivascular, Inc. | Inflatable porous implants and methods for drug delivery |
| EP1718245A4 (en) | 2004-02-12 | 2008-03-19 | Univ Akron | MECHANICALLY APPLIED COATINGS OF MEDICAL DEVICES |
| CA2560507C (en) | 2004-03-26 | 2011-08-16 | Surmodics, Inc. | Composition and method for preparing biocompatible surfaces |
| CN101580968B (zh) | 2004-04-01 | 2011-07-27 | 纳幕尔杜邦公司 | 形成均匀材料的旋转法 |
| US7134857B2 (en) | 2004-04-08 | 2006-11-14 | Research Triangle Institute | Electrospinning of fibers using a rotatable spray head |
| EP1605014A1 (en) | 2004-06-09 | 2005-12-14 | SOLVAY POLYOLEFINS EUROPE - BELGIUM (Société Anonyme) | Polyethylene pipe fitting resins |
| US7297158B2 (en) | 2004-06-14 | 2007-11-20 | Thoratec Corporation | Multilayer composite vascular access graft |
| US7413575B2 (en) | 2004-08-30 | 2008-08-19 | Phaneuf Matthew D | Nanofibrous biocomposite prosthetic vascular graft |
| DE102004058924A1 (de) | 2004-12-07 | 2006-06-08 | Roche Diagnostics Gmbh | Testelement mit Nanofasern |
| WO2006110197A2 (en) | 2005-03-03 | 2006-10-19 | Icon Medical Corp. | Polymer biodegradable medical device |
| US20060200232A1 (en) | 2005-03-04 | 2006-09-07 | Phaneuf Matthew D | Nanofibrous materials as drug, protein, or genetic release vehicles |
| US8771582B2 (en) | 2005-03-04 | 2014-07-08 | BioScurfaces, Inc. | Electrospinning process for making a textile suitable for use as a medical article |
| US8691543B2 (en) | 2009-11-25 | 2014-04-08 | Worcester Polytechnic Institute | Nanofibrous scaffold comprising immobilized cells |
| CN101170965A (zh) | 2005-03-09 | 2008-04-30 | 田纳西大学研究基金会 | 屏障支架及其用途 |
| US20060233990A1 (en) | 2005-04-13 | 2006-10-19 | Trivascular, Inc. | PTFE layers and methods of manufacturing |
| KR20080008364A (ko) | 2005-05-05 | 2008-01-23 | 헤모텍 아게 | 관 스텐트의 전면 코팅 |
| JP2008540022A (ja) | 2005-05-17 | 2008-11-20 | ナイキャスト リミテッド | 植込み可能な荷電性医療装置 |
| US7850810B2 (en) | 2005-07-29 | 2010-12-14 | Gore Enterprise Holdings, Inc. | Method of making porous self-cohered web materials |
| WO2007024500A1 (en) | 2005-08-25 | 2007-03-01 | Medtronic Vascular, Inc. | Controlled radical polymerization-derived block copolymer compositions for medical device coatings |
| WO2007053592A2 (en) | 2005-10-31 | 2007-05-10 | Cook Incorporated | Composite stent graft |
| US7981353B2 (en) | 2005-12-12 | 2011-07-19 | University Of Washington | Method for controlled electrospinning |
| US7828766B2 (en) | 2005-12-20 | 2010-11-09 | Advanced Cardiovascular Systems, Inc. | Non-compliant multilayered balloon for a catheter |
| WO2007090102A2 (en) | 2006-01-27 | 2007-08-09 | The Regents Of The University Of California | Biomimetic scaffolds |
| US9622850B2 (en) | 2006-02-28 | 2017-04-18 | C.R. Bard, Inc. | Flexible stretch stent-graft |
| US8585753B2 (en) | 2006-03-04 | 2013-11-19 | John James Scanlon | Fibrillated biodegradable prosthesis |
| ES2405945T3 (es) | 2006-03-28 | 2013-06-04 | Lnk Chemsolutions, Llc. | Método de manufactura de apósitos hemostáticos fibrosos |
| US8303874B2 (en) | 2006-03-28 | 2012-11-06 | E I Du Pont De Nemours And Company | Solution spun fiber process |
| US8048150B2 (en) | 2006-04-12 | 2011-11-01 | Boston Scientific Scimed, Inc. | Endoprosthesis having a fiber meshwork disposed thereon |
| US7790273B2 (en) | 2006-05-24 | 2010-09-07 | Nellix, Inc. | Material for creating multi-layered films and methods for making the same |
| US20090127748A1 (en) | 2006-07-05 | 2009-05-21 | Panasonic Corporation | Method and apparatus for producing nanofibers and polymeric webs |
| KR100845239B1 (ko) | 2006-08-07 | 2008-07-10 | 한국과학기술연구원 | 내열성 초극세 섬유층을 지닌 분리막 및 이를 이용한이차전지 |
| US20100013126A1 (en) | 2006-08-21 | 2010-01-21 | Michael Ishaque | Process for producing nano- and mesofibers by electrospinning colloidal dispersions |
| US8673099B2 (en) | 2006-09-14 | 2014-03-18 | C. R. Bard, Inc. | Compressed inner covering hinged segmented stent-graft |
| CA2663220A1 (en) | 2006-09-15 | 2008-03-20 | Boston Scientific Limited | Medical devices and methods of making the same |
| US9622888B2 (en) | 2006-11-16 | 2017-04-18 | W. L. Gore & Associates, Inc. | Stent having flexibly connected adjacent stent elements |
| US20080118541A1 (en) | 2006-11-21 | 2008-05-22 | Abbott Laboratories | Use of a terpolymer of tetrafluoroethylene, hexafluoropropylene, and vinylidene fluoride in drug eluting coatings on medical devices |
| US20100190254A1 (en) | 2006-12-05 | 2010-07-29 | Nanyang Technological University | Three-dimensional porous hybrid scaffold and manufacture thereof |
| US7857608B2 (en) | 2006-12-08 | 2010-12-28 | Spindynamics, Inc. | Fiber and nanofiber spinning apparatus |
| US20130150943A1 (en) | 2007-01-19 | 2013-06-13 | Elixir Medical Corporation | Biodegradable endoprostheses and methods for their fabrication |
| JP5973121B2 (ja) | 2007-01-30 | 2016-08-23 | ユニバーシティ オブ ピッツバーグ オブ ザ コモンウェルス システム オブ ハイヤー エデュケイション | 生体内分解性ラッピングおよびその使用 |
| US20080188923A1 (en) * | 2007-02-01 | 2008-08-07 | Jack Fa-De Chu | Endovascular devices to protect aneurysmal wall |
| WO2008097592A2 (en) | 2007-02-05 | 2008-08-14 | Boston Scientific Limited | Synthetic composite structures |
| US20080208325A1 (en) * | 2007-02-27 | 2008-08-28 | Boston Scientific Scimed, Inc. | Medical articles for long term implantation |
| US8277711B2 (en) | 2007-03-29 | 2012-10-02 | E I Du Pont De Nemours And Company | Production of nanofibers by melt spinning |
| US20090018643A1 (en) | 2007-06-11 | 2009-01-15 | Nanovasc, Inc. | Stents |
| WO2008156683A1 (en) | 2007-06-13 | 2008-12-24 | Med Institute, Inc. | Stent attachment for endovascular aneurysm repair |
| US7498079B1 (en) | 2007-06-13 | 2009-03-03 | Toray Fluorofibers (America), Inc. | Thermally stable polytetrafluoroethylene fiber and method of making same |
| US20080319535A1 (en) | 2007-06-25 | 2008-12-25 | Medtronic Vascular, Inc. | Vascular Stent and Method of Making Vascular Stent |
| KR100932688B1 (ko) | 2007-07-06 | 2009-12-21 | 한국과학기술연구원 | 인공혈관용 이중막 구조의 튜브형 다공성 스캐폴드 및 그의제조방법 |
| EP2195068B1 (en) | 2007-09-12 | 2017-07-26 | Cook Medical Technologies LLC | Balloon catheter for delivering a therapeutic agent |
| US8663309B2 (en) | 2007-09-26 | 2014-03-04 | Trivascular, Inc. | Asymmetric stent apparatus and method |
| CN101917929A (zh) | 2007-10-04 | 2010-12-15 | 特里瓦斯库拉尔公司 | 用于低型面经皮递送的模块化脉管移植物 |
| CA2704947C (en) | 2007-11-05 | 2017-09-12 | Louisiana State University Health Sciences Center Office Of Research | Coated devices and method of making coated devices that reduce smooth muscle cell proliferation and platelet activity |
| US7799261B2 (en) | 2007-11-30 | 2010-09-21 | Cook Incorporated | Needle-to-needle electrospinning |
| US9834865B2 (en) | 2007-12-17 | 2017-12-05 | E I Du Pont De Nemours And Company | Centrifugal solution spun nanofiber process |
| WO2009086015A2 (en) | 2007-12-21 | 2009-07-09 | Boston Scientific Scimed, Inc. | Flexible stent-graft device having patterned polymeric coverings |
| JP5396032B2 (ja) | 2008-03-25 | 2014-01-22 | テルモ株式会社 | 拡張カテーテル |
| US20090248131A1 (en) | 2008-03-31 | 2009-10-01 | Medtronic Vascular, Inc. | Covered Stent and Method of Making Same |
| JP5140476B2 (ja) | 2008-03-31 | 2013-02-06 | アズビル株式会社 | 異常検出方法および異常検出装置 |
| CZ2008226A3 (cs) | 2008-04-15 | 2009-10-29 | Elmarco S.R.O. | Zpusob výroby nanovláken z fluorovaných kopolymeru a terpolymeru elektrostatickým zvláknováním, nanovlákna a textilie |
| US8771332B2 (en) | 2008-05-29 | 2014-07-08 | Boston Scientific Scimed, Inc. | Multi-layer balloon design for use in combination with catheter assemblies, and methods of making the same |
| US20090319034A1 (en) | 2008-06-19 | 2009-12-24 | Boston Scientific Scimed, Inc | METHOD OF DENSIFYING ePTFE TUBE |
| US20100042199A1 (en) | 2008-08-18 | 2010-02-18 | Burton David G | Dilation balloon catheter and methods of use thereof |
| US20100042198A1 (en) | 2008-08-18 | 2010-02-18 | Burton David G | Single piece double wall dilation balloon catheter |
| US8394138B2 (en) | 2008-09-05 | 2013-03-12 | Cook Medical Technologies Llc | Multi-strand helical stent |
| US8226603B2 (en) | 2008-09-25 | 2012-07-24 | Abbott Cardiovascular Systems Inc. | Expandable member having a covering formed of a fibrous matrix for intraluminal drug delivery |
| US8524140B2 (en) | 2008-10-02 | 2013-09-03 | Panasonic Corporation | Process of making nanofibers |
| US8852621B2 (en) | 2008-10-07 | 2014-10-07 | Nanonerve, Inc. | Multilayer fibrous polymer scaffolds, methods of production and methods of use |
| US8470236B2 (en) | 2008-11-25 | 2013-06-25 | E I Du Pont De Nemours And Company | Process of making a non-woven web |
| KR20100077913A (ko) | 2008-12-29 | 2010-07-08 | (주)엔티시 | 원심전기방사장치 |
| IT1394522B1 (it) | 2009-01-09 | 2012-07-05 | Invatec Technology Ct Gmbh | Dispositivo medicale con rilascio di farmaco |
| US20130268062A1 (en) | 2012-04-05 | 2013-10-10 | Zeus Industrial Products, Inc. | Composite prosthetic devices |
| US20130238086A1 (en) | 2009-01-16 | 2013-09-12 | Zeus Industrial Products, Inc. | Electrospun PTFE Encapsulated Stent & Method of Manufature |
| DK2384375T3 (en) | 2009-01-16 | 2017-10-16 | Zeus Ind Products Inc | ELECTROSPINING PTFE WITH HIGH-VISUAL MATERIALS |
| WO2010132636A1 (en) * | 2009-05-13 | 2010-11-18 | President And Fellows Of Harvard College | Methods and devices for the fabrication of 3d polymeric fibers |
| CN101584612B (zh) | 2009-06-12 | 2011-11-09 | 广州迈普再生医学科技有限公司 | 一种基于原位自体干细胞技术的再生型人工血管及其制备方法 |
| US20110087318A1 (en) | 2009-10-09 | 2011-04-14 | Daugherty John R | Bifurcated highly conformable medical device branch access |
| US8637109B2 (en) | 2009-12-03 | 2014-01-28 | Cook Medical Technologies Llc | Manufacturing methods for covering endoluminal prostheses |
| DE102010010553A1 (de) | 2010-03-05 | 2011-09-08 | Carl Freudenberg Kg | Verfahren zur Herstellung von Fasern aus Polymerdispersionen |
| WO2012044453A1 (en) * | 2010-09-30 | 2012-04-05 | Cook Medical Technologies Llc | Soft crowns |
| EP2563956A4 (en) | 2010-10-14 | 2013-09-18 | Zeus Ind Products Inc | ANTIMICROBIAL SUBSTRATE |
| WO2012103501A1 (en) | 2011-01-28 | 2012-08-02 | Merit Medical Systems, Inc. | Electrospun ptfe coated stent and method of use |
| US8647540B2 (en) | 2011-02-07 | 2014-02-11 | Fiberio Technology Corporation | Apparatuses having outlet elements and methods for the production of microfibers and nanofibers |
| US8609249B2 (en) | 2011-02-09 | 2013-12-17 | Phillips Scientific Inc. | Thin wall expandable polymer tubes having improved axial and radial strength, and a method of manufacturing thereof |
| BR112013023067A2 (pt) | 2011-03-09 | 2017-07-25 | Univ Texas | aparelhos e métodos para a produção de fibras |
| US20120316633A1 (en) | 2011-06-07 | 2012-12-13 | Boston Scientific Scimed, Inc. | Durable Stent Drug Eluting Coating |
| EP2546394B1 (en) | 2011-07-15 | 2018-04-18 | Cook Medical Technologies LLC | Method of making a stent graft by electrospinning |
| CN103826669A (zh) | 2011-09-23 | 2014-05-28 | 宙斯工业产品股份有限公司 | 复合假体分流器装置 |
| AU2013209965B2 (en) | 2012-01-16 | 2016-06-30 | Merit Medical Systems, Inc. | Rotational spun material covered medical appliances and methods of manufacture |
| US9775933B2 (en) | 2012-03-02 | 2017-10-03 | W. L. Gore & Associates, Inc. | Biocompatible surfaces and devices incorporating such surfaces |
| US20140012304A1 (en) | 2012-07-03 | 2014-01-09 | Merit Medical Systems, Inc. | Multilayered balloon |
| US10835366B2 (en) | 2012-08-16 | 2020-11-17 | Phraxis Inc. | Arterial and venous anchor devices forming an anastomotic connector and system for delivery |
| US11541154B2 (en) | 2012-09-19 | 2023-01-03 | Merit Medical Systems, Inc. | Electrospun material covered medical appliances and methods of manufacture |
| US9198999B2 (en) | 2012-09-21 | 2015-12-01 | Merit Medical Systems, Inc. | Drug-eluting rotational spun coatings and methods of use |
| US10154918B2 (en) | 2012-12-28 | 2018-12-18 | Cook Medical Technologies Llc | Endoluminal prosthesis with fiber matrix |
| WO2014159710A1 (en) | 2013-03-13 | 2014-10-02 | Merit Medical Systems, Inc. | Serially deposited fiber materials and associated devices and methods |
| US9827703B2 (en) | 2013-03-13 | 2017-11-28 | Merit Medical Systems, Inc. | Methods, systems, and apparatuses for manufacturing rotational spun appliances |
| HK1221632A1 (zh) | 2013-09-13 | 2017-06-09 | Abbott Cardiovascular Systems Inc. | 緶織支撐架 |
| EP3096713B1 (en) | 2014-01-23 | 2022-09-21 | President and Fellows of Harvard College | Engineered polymeric valves, tubular structures and sheets |
| WO2015172028A1 (en) | 2014-05-08 | 2015-11-12 | Secant Medical, Inc. | Composite lumen with reinforcing textile and matrix |
| CA3285239A1 (en) | 2015-02-26 | 2025-11-29 | Merit Medical Systems Inc | Layered medical appliances and methods |
| WO2016145163A1 (en) | 2015-03-11 | 2016-09-15 | Board Of Regents Of The University Of Nebraska | Automated retrievable hemorrhage control system |
| US10405963B2 (en) | 2015-11-16 | 2019-09-10 | The Trustees Of Princeton University | Method of producing a 3D subject specific biomimetic nerve conduit |
| US10835394B2 (en) | 2016-05-31 | 2020-11-17 | V-Wave, Ltd. | Systems and methods for making encapsulated hourglass shaped stents |
| CN109475402A (zh) | 2016-06-21 | 2019-03-15 | 美敦力瓦斯科尔勒公司 | 用于动脉瘤治疗的涂覆的血管内假体 |
| US10814041B2 (en) | 2017-08-29 | 2020-10-27 | Cook Medical Technologies Llc | Graft material and method of use thereof |
| US10271977B2 (en) | 2017-09-08 | 2019-04-30 | Vesper Medical, Inc. | Hybrid stent |
| IES87255Y1 (en) | 2018-07-12 | 2021-09-01 | Medibrane Ltd | Article of manufacture comprising stent and fabric |
-
2013
- 2013-01-15 AU AU2013209965A patent/AU2013209965B2/en active Active
- 2013-01-15 DK DK13738588.6T patent/DK2804637T3/da active
- 2013-01-15 CN CN201910026236.5A patent/CN110064076A/zh active Pending
- 2013-01-15 EP EP13738588.6A patent/EP2804637B1/en active Active
- 2013-01-15 US US13/742,025 patent/US9987833B2/en active Active
- 2013-01-15 KR KR1020147019313A patent/KR102037543B1/ko active Active
- 2013-01-15 CA CA2856305A patent/CA2856305C/en active Active
- 2013-01-15 EP EP19193202.9A patent/EP3626276A1/en active Pending
- 2013-01-15 WO PCT/US2013/021554 patent/WO2013109528A1/en not_active Ceased
- 2013-01-15 US US13/742,077 patent/US11623438B2/en active Active
- 2013-01-15 CN CN201380005709.4A patent/CN104114201A/zh active Pending
- 2013-01-15 BR BR112014016892A patent/BR112014016892B1/pt active IP Right Grant
- 2013-01-15 JP JP2014552378A patent/JP6300732B2/ja active Active
- 2013-11-15 US US14/081,715 patent/US20140072694A1/en not_active Abandoned
- 2013-11-15 US US14/081,504 patent/US10005269B2/en active Active
-
2015
- 2015-08-21 US US14/832,422 patent/US10675850B2/en active Active
-
2020
- 2020-06-08 US US16/895,975 patent/US20200369016A1/en active Pending
- 2020-06-08 US US16/896,013 patent/US20200369017A1/en active Pending
-
2021
- 2021-10-29 US US17/515,236 patent/US20220048285A1/en active Pending
-
2023
- 2023-02-16 US US18/170,364 patent/US20230311472A1/en active Pending
-
2024
- 2024-03-29 US US18/622,269 patent/US20240253343A1/en active Pending
-
2025
- 2025-01-17 US US19/027,746 patent/US20250236104A1/en active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20090280325A1 (en) * | 2008-03-17 | 2009-11-12 | Karen Lozano | Methods and apparatuses for making superfine fibers |
| WO2011017698A1 (en) * | 2009-08-07 | 2011-02-10 | Zeus, Inc. | Prosthetic device including electrostatically spun fibrous layer and method for making the same |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2023277264A1 (ko) * | 2021-06-30 | 2023-01-05 | (재)예수병원유지재단 | 스텐트 그래프트 |
| KR20230003874A (ko) * | 2021-06-30 | 2023-01-06 | (재)예수병원유지재단 | 스텐트 그래프트 |
| KR102609978B1 (ko) | 2021-06-30 | 2023-12-06 | (재)예수병원유지재단 | 스텐트 그래프트 |
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20250236104A1 (en) | Rotational spun material covered medical appliances and methods of manufacture | |
| US20230191005A1 (en) | Electrospun material covered appliances and methods of manufacture | |
| US12396837B2 (en) | Electrospun PTFE coated stent and method of use |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PA0105 | International application |
Patent event date: 20140711 Patent event code: PA01051R01D Comment text: International Patent Application |
|
| PG1501 | Laying open of application | ||
| A201 | Request for examination | ||
| PA0201 | Request for examination |
Patent event code: PA02012R01D Patent event date: 20171103 Comment text: Request for Examination of Application |
|
| E902 | Notification of reason for refusal | ||
| PE0902 | Notice of grounds for rejection |
Comment text: Notification of reason for refusal Patent event date: 20190211 Patent event code: PE09021S01D |
|
| E701 | Decision to grant or registration of patent right | ||
| PE0701 | Decision of registration |
Patent event code: PE07011S01D Comment text: Decision to Grant Registration Patent event date: 20190724 |
|
| GRNT | Written decision to grant | ||
| PR0701 | Registration of establishment |
Comment text: Registration of Establishment Patent event date: 20191022 Patent event code: PR07011E01D |
|
| PR1002 | Payment of registration fee |
Payment date: 20191022 End annual number: 3 Start annual number: 1 |
|
| PG1601 | Publication of registration | ||
| PR1001 | Payment of annual fee |
Payment date: 20221017 Start annual number: 4 End annual number: 4 |
|
| PR1001 | Payment of annual fee |
Payment date: 20230918 Start annual number: 5 End annual number: 5 |
|
| PR1001 | Payment of annual fee |
Payment date: 20240919 Start annual number: 6 End annual number: 6 |